The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

about

The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

Item

http://www.wikidata.org/entity/Q45365447

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

@en

The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

@nl

type

Item

label

The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

@en

The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

@nl

prefLabel

The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

@en

The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

@nl

P1476

The potential of virus-based gene therapies for treatment of metastatic kidney cancer.

@en

P2093

Paul B Fisher

http://www.w3.org/2001/XMLSchema#string

P2860

Current developments in adenovirus-based cancer gene therapy

Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cells

MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism.

Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma

PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.

Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice.

The development of MDA-7/IL-24 as a cancer therapeutic

A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases.

Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24

Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery

P304

809-811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1586/ERA.11.59

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David T. Curiel

Paul Dent

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21707273

http://www.w3.org/2001/XMLSchema#string